Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICN Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Johnnie W. who wrote (807)	4/1/1998 5:44:00 PM
From: Carl Wysocki	Read Replies (2) \| Respond to of 1029

Johnnie, I'm not sure a takeover is good for those of us who have stars in our eyes about the future prospects for ICN. Somehow a 30-40% premium to today's price doesn't get me too excited. Fellow poster IJF, on the Yahoo board, proposed $250 by 2002 (forgive me if my recollection is wrong). While I probably disagree with his PE multiple projection (I think its 40), it's not outside the realm of possibilities (hell, Martians may land by then). Now, if ICN does sell for $250 then, and then they want to pay a decent premium, I'd be more than happy to consider the proposal. Right now, I think we have greater potential as long as ICN remains independent, but I do believe that ICN will be acquired over the next couple of years. Carl